The Safety, Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese T2DM
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Exenatide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SPPS
- Sponsors CSPC Pharma
- 20 Sep 2017 Results assessing the tolerability, pharmacokinetics, pharmacodynamics and efficacy of oral exenatide-4 compared with metformin in Chinese patients with type 2 diabetes mellitus, were published in the Clinical Drug Investigation.
- 20 Sep 2017 Status changed from recruiting to completed, according to results published in the Clinical Drug Investigation.
- 10 Jun 2017 Biomarkers information updated